Results 31 to 40 of about 22,026 (197)

Onychomycosis among Clinically Suspected Cases Attending the Dermatology Out-patient Department of a Tertiary Care Centre: A Descriptive Cross-sectional Study

open access: yesJournal of Nepal Medical Association, 2021
Introduction: Onychomycosis is a fungal disease of the nail apparatus caused by dermatophytes, non-dermatophytes and yeasts. Although onychomycosis is rarely life threatening, its high incidence and the associated morbidity makes it an important public ...
Beena Jha   +3 more
doaj   +1 more source

Demystifying fungal systematics: A gateway to fungal literacy and societal/ecological relevance through familiar species

open access: yesPLANTS, PEOPLE, PLANET, EarlyView.
Fungal systematics can feel overwhelming given the vast species diversity within this kingdom, with numerous subgroups at every taxonomic rank. This often creates a disconnect between the undertsnidng of fungal taxonomic diversity and their societal relevance.
Anna Vaiana   +4 more
wiley   +1 more source

The prevalence of onychomycosis in patients with chronic renal failure undergoing dialysis: A cross-sectional study

open access: yesHeliyon
Onychomycosis is one of the most common cutaneous symptoms in patients with chronic renal failure. In the present study, we aimed to investigate the prevalence and determine the factors likely associated with developing onychomycosis among dialysis ...
Hojat Eftekhari   +5 more
doaj   +1 more source

Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Dermatophyte infections of the dermis and subcutaneous tissue (i.e. deep dermatophytosis)—associated with secondary complications including pseudomycetoma and systemic dissemination—affect vulnerable populations with primary or acquired immunodeficiencies.
Aditya K. Gupta   +5 more
wiley   +1 more source

Case Study of Onychomycosis Patients Treated with 1,064-nm Nd:YAG Laser

open access: yesCase Reports in Dermatology, 2018
Onychomycosis is the most frequent nail disease, with an estimated prevalence of 2–8%. Current treatment strategies include the use of oral and topical antifungals, despite low cure rates following these treatments.
Rachel Bertolani do Espírito Santo   +1 more
doaj   +1 more source

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 728-740, January 2026.
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo   +8 more
wiley   +1 more source

A rare case of onychomycosis due to Aspergillus species in a neonate

open access: yesIndian Journal of Paediatric Dermatology, 2019
Onychomycosis is a common condition affecting 5.5% of the population worldwide and represents 20%–40% of all onychopathies and about 30% of cutaneous mycotic infections. It is common in elderly, uncommon in children, and rare in neonates.
Kuldeep Verma   +3 more
doaj   +1 more source

What Is the Diagnostic Capacity of Existing Severity Scoring Tools for Nail Psoriasis?

open access: yesInternational Journal of Dermatology, Volume 65, Issue 1, Page 86-92, January 2026.
ABSTRACT Background It is challenging to distinguish nail psoriasis (NP) from nonspecific nail changes, contributing to heterogeneity in clinical trials. Existing scoring tools for NP are currently used to assess severity after diagnosis is established.
Evi C. C. Rikken   +5 more
wiley   +1 more source

Polishing the Therapy of Onychomycosis Induced by Candida spp.: Amphotericin B–Loaded Nail Lacquer [PDF]

open access: gold, 2021
Aleph M. S. Souza   +10 more
openalex   +1 more source

Infrared Spectroscopy as a Promising Tool for Diagnosing and Typing Human Pathogenic Fungi

open access: yesMycoses, Volume 69, Issue 1, January 2026.
ABSTRACT Fungal infections are increasingly recognised as a global health challenge, responsible for millions of cases annually and substantial mortality, especially in immunocompromised individuals. Yet, the diagnosis of these infections remains notoriously difficult, often delayed by slow culture‐based methods or hindered by the high cost and ...
Anthony G. J. Medeiros   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy